395 related articles for article (PubMed ID: 12909410)
21. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
22. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route.
Burkhard MJ; Mathiason CK; O'Halloran K; Hoover EA
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):217-26. PubMed ID: 11839157
[TBL] [Abstract][Full Text] [Related]
24. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats.
Lappin MR; George JW; Pedersen NC; Barlough JE; Murphy CJ; Morse LS
J Parasitol; 1996 Oct; 82(5):733-42. PubMed ID: 8885881
[TBL] [Abstract][Full Text] [Related]
25. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
26. Vaccination against feline immunodeficiency virus using fixed infected cells.
Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
[TBL] [Abstract][Full Text] [Related]
27. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
[TBL] [Abstract][Full Text] [Related]
28. Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesis.
Mikkelsen SR; Long JM; Zhang L; Galemore ER; VandeWoude S; Dean GA
PLoS One; 2011 Feb; 6(2):e17183. PubMed ID: 21364928
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
[TBL] [Abstract][Full Text] [Related]
31. Transmission of feline immunodeficiency virus from infected queens to kittens.
Wasmoen T; Armiger-Luhman S; Egan C; Hall V; Chu HJ; Chavez L; Acree W
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):83-93. PubMed ID: 1337404
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus.
Reche A; Daniel AG; Lazaro Strauss TC; Taborda CP; Vieira Marques SA; Haipek K; Oliveira LJ; Monteiro JM; Kfoury JR
J Feline Med Surg; 2010 Apr; 12(4):355-8. PubMed ID: 20156698
[TBL] [Abstract][Full Text] [Related]
33. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
[TBL] [Abstract][Full Text] [Related]
34. An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases.
Dua N; Reubel G; Moore PF; Higgins J; Pedersen NC
Vet Immunol Immunopathol; 1994 Nov; 43(4):337-55. PubMed ID: 7856070
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies.
Bull ME; Vahlenkamp TW; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 2004 May; 99(1-2):25-37. PubMed ID: 15113651
[TBL] [Abstract][Full Text] [Related]
36. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
Rideout BA; Moore PF; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B.
Phadke AP; de la Concha-Bermejillo A; Wolf AM; Andersen PR; Baladandayuthapani V; Collisson EW
Vet Microbiol; 2006 Jun; 115(1-3):64-76. PubMed ID: 16574348
[TBL] [Abstract][Full Text] [Related]
38. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.
VandeWoude S; Hageman CL; Hoover EA
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):20-31. PubMed ID: 14501789
[TBL] [Abstract][Full Text] [Related]
39. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
40. Altered surface antigen expression on peripheral blood mononuclear cells in cats infected with feline immunodeficiency virus.
Ohno K; Watari T; Goitsuka R; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1992 Jun; 54(3):517-22. PubMed ID: 1322715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
